Management of Neuropathic Pain in Complex Regional Pain Syndrome: A Comprehensive Review
Pain Practice · 2026-11 · 26 (8)
DOI: 10.1111/papr.70197 ↗Abstract
ABSTRACT Objective Complex regional pain syndrome (CRPS) is a complex and multifaceted condition in which pain may be neuropathic, nociplastic, nociceptive, or mixed in nature. This review aims to summarize the available pharmacological and non‐pharmacological strategies for managing neuropathic pain in CRPS Types I and II. Methods Scopus, PubMed, Cochrane Library, and Google Scholar were searched for randomized controlled trials, meta‐analyses, case series, and case reports addressing the management of CRPS, with a focus on neuropathic pain. Studies were analyzed from the perspective of pharmacological and non‐pharmacological approaches, with attention to differences between CRPS Type I and II. Results Gabapentin (Level 1 evidence) and physiotherapy (Level 2 evidence) showed the strongest support among the treatments reviewed. Evidence remains limited or inconsistent for other pharmacological options (e.g., anticonvulsants other than gabapentin, opioids, antidepressants, ketamine, botulinum toxin) and for non‐pharmacological interventions (e.g., mirror therapy, spinal cord stimulation, acupuncture). No significant differences in treatment efficacy were identified between CRPS Type I and II. Conclusion Given the complex and heterogeneous nature of CRPS, a multimodal, individualized treatment approach is recommended. Further well‐structured studies are needed to strengthen the evidence base for the management of neuropathic pain in CRPS.
EUVIMED